Indeed, the increase in proliferation rate observed in prostate cancer cell line models in response to IL-6 has been demonstrate to be via activation of STAT3 (Dhir et al, 2002; Godoy-Tundidor et al, 2005; Sanford and Dewille, 2005). The gene discussed is STAT3; the disease is prostate carcinoma.